Tailor-Made Private Equity
Healthtech & Sustainable Innovation

We empower private investors to back world-class innovative companies from the very beginning

Become an InvestorSubmit your deck
Meet us

20 yrs

of investment experience, from seed to series A



6 deals

per year, carefully sourced and delivered


25k€

minimum ticket to join  us on a deal

Ancd Biomed

Healthcare - next generation of catheters

ShaPr

Software - Shapr boosts startups' growth

Ancd Biomed

Healthcare - delivering therapies for hearing

EverReady.AI

SaaS - CRM automation for sales teams

With a solid track record

We source deals across Europe, in high end verticals, and conduct deep-dive due diligence

Verticals you don't
see every day.

Class II and III Medical Devices
Digital Health Solutions
AI-related softwares and DTx
We chase European startups wherever they are

Our Portfolio

JOOL

PRIMAA is an AI-powered software capable of detecting all cancer biomarkers.
WEBSITE

PRIMAA

PRIMAA is an AI-powered software capable of detecting all cancer biomarkers.
WEBSITE

AVATAR

AVATAR MEDICAL™ creates patient avatars to help surgeons visualize medical images.
WEBSITE

PANDOBAC

Pandobac helps you make the transition  to reusable packaging.
WEBSITE

ASKEL

Askel created COPLA®, a medical device for cartilage repair.
WEBSITE

METYOS

Metyos sells a biosensor tracking real-time dynamic data.
WEBSITE

KARD

Kard is a dual-purpose banking app for teenagers.
WEBSITE

VINTEGA

Vintega sells online pre-owned luxury
bags.
WEBSITE

EVERREADY

EverReady instantly updates your CRM all your contacts and sales activities
WEBSITE

We have skin in the game.

We only share deals we invest in,
with a carried indexed on performance.

100%

We invest in every single deal we share

>50%

Of our comittee must accept the deal for it to go through

20%

Carried indexed on performance


Modern tools to pick your deals.

Through an inhouse developped investment platform

Step 1

Subscribe to our platform in a few clicks

Step 2

Receive deals with investment note directly in your inbox

Step 3

Choose whether to invest or not, with a 100% online investment process

We are contrarians

A team composed of the founder of seed fund Pi2, along with the co-founder of a leading financial advising firm Impulse Corporate Finance.

Fred Picq, Partner

Fred has been Head Trader for over 10 years in NYC and Geneva at Ziff Brothers Investments, one of the world's biggest Family Offices. He then founded venture capital fund Pi2 driven by his passion for technology and entrepreneurship. He is visionary, agile and creative.

Clovis Tuffier, Partner

Clovis co-founded M&A firm Impulse CF where he has been focusing on technology transactions for high-growth businesses. He is adept at leadership,  and has a forward-looking approach,with a keen understanding of market trends and the dynamic landscape of the Venture Capital ecosystem.

Andrea Baridon, Associate

As a valuable member of CENITZ, Andrea finds resonance in the club deal's entrepreneurial spirit, purposeful focus, and commitment to fostering innovation. By leveraging his strategic acumen, he brings a unique perspective when evaluating new investment opportunities.

If they say no, it's no.

Meet our insiders, who
curate every deal

Charles Tétard

Managing Partner and cofounder of Impulse CF, completed more than 40 transactions

Olivier Edwards

Senior Counsel & Laywer, Orrick, member of Technology Companies Group, co-founder European Bureau of SV

Richard Tuffier

President, Buy for Good, ex MD ODDO BHF, Business Angel

Niels Court-Payen

President & Co-founder, A Plus Finance (managing $1bn+), ex PAI – Paribas Affaires Industrielles

Hervé Digne

Co-founder Post Advisors, CEO Postmedia Finance, President Manifesto, ENA & Sciences Po

Bernard Grouchko

Founder GL trade (exit 2008), ex-mayor of Le Vesinet, founder Green Recovery

Robert Picarel

Founder, Velvet Consulting (exit 2020), Co-founder Pi2, private equity investor

Clément Jeanjean

Founder Scentys, COO Cryptosense, Co-founder DraftQuest & Ascent Consult

Pierre Besson

Founder, Alpha Partners,
Partner at M&A firm Impulse CF, ex Eight Advisory & Meeschaert

Laurent Ferté

Partner & CEO at Adhesion & Associés(exited 1998), experienced private equity investor

Better than investing in a fund:
you can always follow your guts

Deep dive due diligence
Competitive fee structure
Monitoring of participation
6%

fee excl. VAT

At the time of the deployment of funds to cover structural costs

20%

carried interest

Success driven
business model



0.4%

Annual fees

You're charged only when you invest, and such fees are reimbursed upon exit

Invest with us.
Become a Sider.

Start your journey

Our Stories

Reimbursement Policies Are Stifling Innovation in European Healthcare
October 1, 2024
English
For healthcare startups, reimbursement is the main gateway to revenue and the ability to scale. Without clear, predictable reimbursement processes, startups are hesitant to invest in expensive research and development.
Impact & Healthcare: It Is Not What You Think!
April 11, 2024
English
In Healthcare, there are many different ways to impact investing. Not the same goals, not the same reasons, not the same ambitions. The potential for positive change is infinite, let's delve into these ways.
Democracy at Risk: The Rising Threat of Tech Giants
November 29, 2023
English
In an era where technology dictates pace, the GAFAM giants — Google, Amazon, Facebook, Apple, and Microsoft — & company are becoming the game itself. Are they edging out the role of nation-states?
High-Tech AI Brains vs Timeless Beauty of Human Hands
November 1, 2023
English
Embark on a thrilling journey through the evolution of technology.This story unfolds starting from the pioneering breakthroughs of early physicists to the awe-inspiring realm of AI.
Le retour des Pigeons: avis aux fondateurs de startups
December 1, 2022
French
Alors qu’une grande part de la valeur créée par l’écosystème provient des fondateurs de startups, ceux-ci sont souvent lésés lors des multiples tours de financement qui adviennent.
Pourquoi investir dans les Medtech ?
May 1, 2021
French
Le secteur de la Medtech (ou technologie médicale) se compose de 2 secteurs principaux: les appareils médicaux et les diagnostics. Les appareils médicaux (seringue, cathéther, implant…) constituent la catégorie historiquement la plus importante (>90%).
@Cenitz 2021
83 avenue Charles de Gaulle - 92200 Neuilly-sur-Seine
+33 (0) 1 74 54 93 86